Cytokine mRNA expression in mononuclear cells from different tissues during acute SIVmac251 infection of Macaques

AIDS Research and Human Retroviruses

Volumn 12, Issue 13, 1996, Pages 1263-1272

  Chéret, Arnaud ^a,b   Le Grand, Roger ^a   Caufour, Philippe ^a   Dereuddre Bosquet, Nathalie ^a   Matheux, Franck ^a   Neildez, Olivier ^a   Théodoro, Frederic ^a   Maestrali, Nicolas ^a   Benveniste, Olivier ^a   Vaslin, Bruno ^a   Dormont, Dominique ^a  

^a Institut Paris Sud sur les Cytokines   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIDANOSINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; LUNG LAVAGE; LYMPH NODE; MACACA; MALE; MONKEY DISEASE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0029794238     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.1263     Document Type: Article

References (55)

1. Barré-Sinoussi F, Chermann J, Rey F, Chamaret S, Gruest J, Dauguet C, Axler-Blin C, Vezinet-Brun F, Rouzioux C, Rozenbaum W, and Montagnier L: Isolation of T-lymphotropic retrovirus from a patient at risk for acquired immunodeficiency syndrome (AIDS). Science 1983;220:868-871.
2. Klatzmann D, Champagne E, Chamaret S, Gruest J, Guetard D, Hercend T, Gluckman J, and Montagnier L: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (London) 1984;312:767-769.
3. Salahuddin SZ, Rose RM, Groopman JE, Markham PD, and Gallo RC: Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 1986;68:281-284.
4. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, and Popovic M: The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986;233:215-219.
5. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, Janotta F, Aksamit A, Martin MA, and Fauci AS: Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 1986;233:1089-1093.
6. Shearer GM and Clerici M: T helper immune dysfunction in asymptomatic, HIV-1-seropositive individuals: The role of TH1-TH2 cross-regulations. Chem Immunol 1992;54:21-43.
7. Meltzer MS, Skillman DR, Gamatos DJ, Kalter DC, and Gendelman HE: Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection. Annu Rev Immunol 1990;8:169-194.
8. Sinicco A, Biglino A, Sciandra M, Forno B, Pollono AM, Raiteri R, and Gionnini P: Cytokine network and acute primary HIV-1 infection. AIDS 1993;7:1167-1172.
9. Diaz-Mitoma F, Kumar A, Karimi S, Kryworuchko M, Daftarian MP, Creery WD, Filion LG, and Cameron W: Expression of IL-10, IL-4 and interferon-gamma in unstimulated and mitogen-stimulated peripheral blood lymphocytes from HIV-seropositive patients. Clin Exp Immunol 1995;102:31-39.
10. Navikas V, Link J, Persson C, Olsson T, Höjeberg B, Ljungdahl A, Link H, and Wahren B: Increased mRNA expression of IL-6, IL-10, TNF-α, and perforin in blood mononuclear cells in human HIV infection. J AIDS Hum Retrovirol 1995;9:484-489.
11. Vicenzi E and Poli G: Regulation of HIV expression by viral genes and cytokines. J Leuk Biol 1994;56:328-334.
12. Levy J: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
13. Von Sydow M, Sönnerborg A, Gaines H, and Strannegard O: Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. AIDS Res Hum Retroviruses 1991;7:375-380.
14. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Kanki PK, Essex M, and Desrosiers RC: Isolation of a T-cell tropic HTLV-III-like retrovirus from macaques. Science 1985;228:1200-1204.
15. Desrosiers RC: The simian immunodeficiency viruses. Annu Rev Immunol 1990;8:557-578.
16. Chakrabarti L, Guyader M, Alizon M, Daniel MD, Desrosiers RC, Tiollais P, and Sonigo P: Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature (London) 1987;328:543-547.
17. Baskin GB, Murphey-Corb M, Watson EA, and Martin LN: Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/Delta. Vet Pathol 1988;25:456-467.
18. Letvin NL and King NW: Immunologic and pathologic manifestations of the infection of rhesus macaques with SIVmac. J AIDS 1990;3:1023-1040.
19. Benveniste O, Vaslin B, Le Grand R, Fouchet P, Omessa V, Theodora F, Fretier P, Clayette P, Boussin F, and Dormont D: Interleukin-1β, interleukin-6, tumor necrosis factor α and interleukin-10 responses in PBMC of cynomolgus macaques during acute infection with SIVmac251. AIDS Res Hum Retroviruses 1996;12:241-250.
20. Clayette P, Le Grand R, Noack O, Vaslin B, Le Naour R, Benveniste O, Théodora O, Frétier P, and Dormont D: Tumor necrosis factor-alpha in serum of macaques during SIVmac251 acute infection. J Med Primatol 1995;24:94-100.
21. Faulds D and Brogden RN: Didanosine: A review of its antiviral activity, pharmocokinetic properties and therapeutic potential in human immunodeficiency virus infection. Drugs 1992;44:94-116.
22. Yerly S, Kaiser L, Baumberger C, Hirschel B, and Perrin LH: Early and prolonged decrease of viremia in HIV-1 infected patients treated with didanosine. J AIDS Hum Retrovirol 1995;8:358-364.
23. Perno CF, Yarchoan R, and Cooney DA: Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′,3′-dideoxythymidine (AZT) and other dideoxynucleoside congeners of thymidine. J Exp Med 1989;169:933-951.
24. Clumeck N: Current use of anti-HIV drugs in AIDS. J Antimicrobiol Chem 1993;32 (Suppl. A): 133-138.
25. Le Grand R, Clayette P, Noack O, Vaslin B, Théodora F, Michel G, Roques P, and Dormont D: An animal model for antilentiviral therapy: Effect of zidovudine on viral load during acute infection after exposure of macaques to simian immunodeficiency virus. AIDS Res Hum Retroviruses 1994;10:1279-1287.
26. Kärber G: Beitrag zur kollektiven behandlung pharmakologischer reihenvesuche. Arch Exp Pathol Pharmak 1931;162:956-959.
27. Le Grand R, Vaslin B, Vogt G, Roques P, Humbert D, Aubertin AM, and Dormont D: AIDS vaccine developments. Nature (London) 1992;355:684.
28. Villinger F, Hunt D, Mayne A, Vichetich M, Findley H, and Ansari AA: Qualitative and quantitative studies of cytokine synthesized and secreted by nonhuman primate peripheral blood mononuclear cells. Cytokine 1993;5:469-479.
29. Benveniste O, Vaslin B, Villinger F, Le Grand R, Ansari AA, and Dormont D: Cytokine mRNA levels in unmanipulated (ex vivo) and in vitro stimulated monkey PBMCs using a semi-quantitative RT-PCR and high sensitivity fluorescence-based detection strategy. Cytokine 1996;8:32-41.
30. Benveniste O, Vaslin .B, Le Grand R, Chéret A, Matheux F, Théodora F, Cranage MP, and Dormont D: Comparative IL-2/IFNγ and IL-10 responses during acute infection of macaques inoculated with attenuated nef-truncated or pathogenic SIVmac251. Proc Natl Acad Sci USA 1996;93:3658-3663.
31. Chakrabarti L, Baptiste L, Khatissian E, Cumont MC, Aubertin AM, Montagnier L, and Hurtrel B: Limited viral spread and rapid immune response in lymph nodes of macaques inoculated with attenuated simian immunodeficiency virus. Virology 1995;213:535-548.
32. Simon MA, Chalifoux LV, and Ringler D: Pathologic features of SIV-induced disease and the association of macrophage infection with disease evolution. AIDS Res Hum Retroviruses 1992;8:327-337.
33. Autran B, Sadat-Sowti B, Hadida F, Parrot A, Guillon JM, Plata F, Mayaud C, and Debré P: HIV-specific cytotoxic T lymphocytes against alveolar macrophages: Specificities and downregulation. Res Virol 1991;142:113-118.
34. Plata F, Autran B, Martins LP, Wain-Obson S, Raphaél M, Mayaud C, Denis M, Guillon J-M, and Debré P: AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature (London) 1987;328:348-351.
35. Autran B, Plata F, Guillon JM, Joly P, Mayaud C, and Debré P: HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients. Res Virol 1990;141: 131-136.
36. + lymphocyte response in acutely infected rhesus monkeys. J Virol 1993;67: 1707-1711.
37. Unger RE, Marthas ML, Lackner AA, Pratt-Lowe E, Lohman BL, Rompay KV, and Luciw PA: Detection of simian immunodeficiency virus DNA in macrophages from infected rhesus macaques. J Med Primatol 1992;21:74-81.
38. Jeffrey AA, Israel-Biet D, Andrieu JM, Even P, and Venet A: HIV isolation from pulmonary cells derived from bronchoalveolar lavage. Clin Exp Immunol 1991;84:488-492.
39. Israel N, Hazan U, Alcami J, Munier A, Arenzana-Seisdedos F, Bachelerie F, Israel A, and Virelizier JL: Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. J Immunol 1989;143:3956-3960.
40. Martinez-Maza O: IL-6 and AIDS. Res Immunol 1992;143: 764-769.
41. Walsh DG, Horvath CJ, Hansen-Moosa A, McKey JJ, Sehgal PK, Daniel MD, Desrosiers RC, and Ringler DJ: Cytokine influence on simian immunodeficiency virus within primary macrophages. Am J Pathol 1991;139:877-587.
42. Weissman D, Poli G, and Fauci AS: IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. J AIDS Hum Retrovirol 1995;9:442-449.
43. Cox RA, Anders GT, Cappelli PJ, Johnson JE, Blanton HM, Seaworth BJ, and Treasure RL: Production of tumor necrosis factor-alpha and interleukin-1 by alveolar macrophages from HIV-1-infected persons. AIDS Res Hum Retroviruses 1990;6:431-441.
44. Israel-Biet D, Cadranel J, Beldjord K, Andrieu M, Jeffrey A, and Even P: Tumor necrosis factor production in HIV-seropositive subjects: Relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J Immunol 1991;147:490-494.
45. Trentin L, Garbisa S, Zambello R, Agostini C, Caenazzo C, DiFrancesco C, Cipriani A, Francavilla E, and Semenzato G: Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. J Infect Dis 1992;166:731-737.
46. Denis M and Ghadirian E: Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res Hum Retroviruses 1994;10:1619-1627.
47. + alveolitis. Clin Exp Immunol 1994;96:187-192.
48. Agostini C, Zambello R, Trentin L, Cerutti A, Enthammer C, Facco M, Milali A, Sancetta R, Garbisa S, and Semenzato G: Expression of TNF receptors by T cells and membrane TNF-α by alveolar macrophages suggests a role for TNF-α in the regulation of local immune responses in the lung of HIV-1 infected patients. J Immunol 1995;154:2928-2938.
49. Tishon A, Lewicki H, Rall G, Von Herrath M, and Oldstone MBA: An essential role for type 1 interferon-γ in terminating persistent viral infection. Virology 1995;212:244-250.
50. Buhl R, Jaffe HA, Holroyd KJ, Borok Z, Roum JH, Matrangeli A, Wells FB, Kirby M, Saltini C, and Crystal RG: Activation of alveolar macrophages in asymptomatic HIV infected individuals. J Immunol 1993;150;1019-1028.
51. Horvath CJ, Desrosiers RC, Sehgal PK, King NW, and Ringler DJ: Effect of simian immunodeficiency virus infection on tumor necrosis factor alpha production by alveolar macrophages. Lab Invest 1991;65:280-286.
52. Poli G, Biswas P, and Fauci AS: Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. Antiviral Res 1994;24:221-233.
53. Castilletti C, Capobianchi MR, Fais S, Abbate I, Ficociello B, Ameglio F, Cordiali Fei P, Santini SM, and Dianzani F: HIV type 1 grown on interferon γ-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res Hum Retroviruses 1995;11:547-553.
54. Böttiger D, Ljungdahl-Ståhle E, and Öberg B: Treatment of acute SIV infection in cynomolgus monkeys with 2′,3′-dideoxyinosine (ddI) and 2′,3′-dideoxythymidiene (d4T). Antiviral Chem Chemother 1991;2:357-361.
55. Biron F, Lucht F, Peyramond D, Fresard A, Vallet T, Nugier F, Grange J, Malley S, Hamedi-Sangsari F, and Vila J: Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1-infected individuals. J AIDS Hum Retrovirol 1995;10:36-40.